Lee Charles Research was formed in 2024 by Private Label Distillery Owner, Paul Thomas Dunning.
Lee is Paul’s mother’s middle name & Charles his father’s middle name. Lee Charles Research mission is to end stage 2 cancers by 2045 through promising DNA fragment cancer testing.
At 44, Paul is fighting stage 4 colon cancer that developed in his mid 30s and he has decided to spend 50% of his remaining time developing cancer prevention, treatment and research (C-PTR).
Lee Charles will start offering Global AI Assisted Clinical Trial Monitoring (GAACTM) by December 31st 2024.
Roughly 18% of patients die from cancer when clinical trials are available simply because the patient does not know about the trial.
Lee Charles Research was formed in 2024 by Private Label Distillery Owner, Paul Thomas Dunning.
Lee is Paul’s mother’s middle name & Charles his father’s middle name. Lee Charles Research mission is to end stage 2 cancers by 2045 through promising DNA fragment cancer testing.
At 44, Paul is fighting stage 4 colon cancer that developed in his mid 30s and he has decided to spend 50% of his remaining time developing cancer prevention, treatment and research (C-PTR).
Lee Charles will start offering Global AI Assisted Clinical Trial Monitoring (GAACTM) by December 31st 2024.
Roughly 18% of patients die from cancer when clinical trials are available simply because the patient does not know about the trial.
100% of profits donated to Lee Charles Research
Customers who like F*ck Cancer Bourbon also viewed
Customers who like F*ck Cancer Bourbon also viewed
